ESR2 and neoplasm: ERβ has been reported as the critical ER in melanocytic lesions [27], and De Giorgi et al. described that the level of ERβ was found to be reduced in thicker and invasive melanoma [28,29], supporting the notion that ERβ might have anti-tumor activity in melanoma [5].